1. Home
  2. ODC vs AVLN Comparison

ODC vs AVLN Comparison

Compare ODC & AVLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oil-Dri Corporation Of America

ODC

Oil-Dri Corporation Of America

HOLD

Current Price

$100.25

Market Cap

1.4B

ML Signal

HOLD

Logo Avalyn Pharma Inc. Common Stock

AVLN

Avalyn Pharma Inc. Common Stock

N/A

Current Price

$29.74

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ODC
AVLN
Founded
1941
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
1994
2026

Fundamental Metrics

Financial Performance
Metric
ODC
AVLN
Price
$100.25
$29.74
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
119.8K
590.5K
Earning Date
06-04-2026
N/A
Dividend Yield
1.13%
N/A
EPS Growth
50.45
N/A
EPS
1.69
N/A
Revenue
$485,572,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$59.37
N/A
Revenue Growth
10.97
N/A
52 Week Low
$45.61
$27.42
52 Week High
$106.84
$33.32

Technical Indicators

Market Signals
Indicator
ODC
AVLN
Relative Strength Index (RSI) 70.98 35.43
Support Level $70.50 $27.42
Resistance Level N/A $33.32
Average True Range (ATR) 3.37 2.96
MACD 0.07 -0.22
Stochastic Oscillator 56.43 39.20

Price Performance

Historical Comparison
ODC
AVLN

About ODC Oil-Dri Corporation Of America

Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups, namely the Retail and Wholesale Products Group, which derives maximum revenue, and the Business-to-Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.

About AVLN Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.

Share on Social Networks: